Lemaitre Vascular (LMAT) Revenue (2010 - 2026)

Lemaitre Vascular (LMAT) has reported Revenue for 17 consecutive years, with $70.4 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Revenue rose 9.57% year-over-year to $70.4 million in Q2 2026; TTM through Jun 2026 was $262.4 million, a 11.85% increase from a year earlier, with the FY2025 full-year figure at $249.6 million, up 13.53% from the prior year.
• Revenue was $70.4 million for Q2 2026 at Lemaitre Vascular, up from $66.6 million in the prior quarter.
• Over five years, Revenue peaked at $70.4 million in Q2 2026 and troughed at $39.0 million in Q3 2022.
• A 5-year average of $53.4 million and a median of $54.1 million in 2024 frame the typical range for Revenue.
• Across the five-year window, Revenue rose 1.72% in 2022 and rose 21.48% in 2023, its largest moves.
• Over 5 years, Revenue stood at $41.0 million in 2022, then increased by 19.36% to $48.9 million in 2023, then gained by 13.98% to $55.7 million in 2024, then increased by 15.68% to $64.5 million in 2025, then gained by 9.2% to $70.4 million in 2026.
• The last three Revenue figures came in at $70.4 million (Q2 2026), $66.6 million (Q1 2026), and $64.5 million (Q4 2025), per Business Quant data.